- Home
- SHOT vs CTXR Comparison
SHOT vs CTXR Comparison
Compare SHOT & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHOT
- CTXR
- Stock Information
- Founded
- SHOT 2018
- CTXR 2007
- Country
- SHOT United States
- CTXR United States
- Employees
- SHOT N/A
- CTXR N/A
- Industry
- SHOT Biotechnology: Pharmaceutical Preparations
- CTXR Biotechnology: Pharmaceutical Preparations
- Sector
- SHOT Health Care
- CTXR Health Care
- Exchange
- SHOT Nasdaq
- CTXR Nasdaq
- Market Cap
- SHOT 31.4M
- CTXR 28.4M
- IPO Year
- SHOT 2020
- CTXR N/A
- Fundamental
- Price
- SHOT $0.42
- CTXR $1.80
- Analyst Decision
- SHOT
- CTXR Strong Buy
- Analyst Count
- SHOT 0
- CTXR 2
- Target Price
- SHOT N/A
- CTXR $54.50
- AVG Volume (30 Days)
- SHOT 583.2K
- CTXR 184.9K
- Earning Date
- SHOT 03-31-2025
- CTXR 02-14-2025
- Dividend Yield
- SHOT N/A
- CTXR N/A
- EPS Growth
- SHOT N/A
- CTXR N/A
- EPS
- SHOT N/A
- CTXR N/A
- Revenue
- SHOT $652,495.00
- CTXR N/A
- Revenue This Year
- SHOT N/A
- CTXR N/A
- Revenue Next Year
- SHOT N/A
- CTXR $216.25
- P/E Ratio
- SHOT N/A
- CTXR N/A
- Revenue Growth
- SHOT 68.01
- CTXR N/A
- 52 Week Low
- SHOT $0.42
- CTXR $1.47
- 52 Week High
- SHOT $2.89
- CTXR $26.75
- Technical
- Relative Strength Index (RSI)
- SHOT 33.14
- CTXR 21.53
- Support Level
- SHOT $0.46
- CTXR $1.47
- Resistance Level
- SHOT $0.51
- CTXR $2.97
- Average True Range (ATR)
- SHOT 0.04
- CTXR 0.29
- MACD
- SHOT 0.01
- CTXR -0.05
- Stochastic Oscillator
- SHOT 0.06
- CTXR 22.00
About SHOT Safety Shot Inc.
Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.